Garth Rapeport is the founder and CEO of Pulmocide, an innovative venture capital funded company that specialises in tackling prevalent, but hard-to-treat respiratory infections.
The company focuses on infections associated with life-threatening... complications that can have significant effects on patients’ quality of life. A unique biopharmaceutical company, Pulmocide Ltd is identifying and developing potent inhaled antifungal and antiviral medicines for life-threatening lung conditions. These include Invasive Aspergillus, RSV (respiratory syncytial virus), asthma and cystic fibrosis.
In order to share a review or your profile you need to publish your profile first, otherwise the link you shared is not accessible to any profile visitor.
Submit a report to ProvenExpert
Quality assurance is the top priority of ProvenExpert's terms of use and evaluation guidelines.
However, should you feel that a review is in violation of our guidelines, you can submit a request to have the review assessed by the ProvenExpert quality assurance team by using the following contact form.
Send email to reviewer
* Required fields
You have already posted this review on . Posting again might create duplication.
Continue?